Haloperidol activates quiescent oligodendroglia precursor cells in the adult mouse brain

Schizophrenia Research

Volumn 119, Issue 1-3, 2010, Pages 164-174

  Wang, Hanzhi ^a   Xu, Haiyun ^b   Niu, Jianqin ^a   Mei, Feng ^a   Li, Xinmin ^c   Kong, Jiming ^c   Cai, Wenqin ^a   Xiao, Lan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Brain; Development; Haloperidol; Oligodendrocytes; Schizophrenia

Indexed keywords

CD68 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; HALOPERIDOL; MYELIN BASIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CORPUS CALLOSUM; HIPPOCAMPUS; IMMUNOREACTIVITY; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRECURSOR; PRIORITY JOURNAL; WHITE MATTER;

ACTINS; ANIMALS; ANTIGENS; ANTIPSYCHOTIC AGENTS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN; CELL COUNT; CELL DIFFERENTIATION; CELL DIVISION; HALOPERIDOL; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; PROTEOGLYCANS; STEM CELLS; UP-REGULATION;

EID: 77952671380     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.02.1068     Document Type: Article

References (58)

1. Aberg K., Saetre P., Jareborg N., Jazin E. Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7482-7487.
2. Bartzokis G., Nuechterlein K.H., Lu P.H., Gitlin M., Rogers S., Mintz J. Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biol. Psychiatry 2003, 53:412-421.
3. Bartzokis G., Lu P.H., Nuechterlein K.H., Gitlin M., Doi C., Edwards N., Lieu C., Altshuler L.L., Mintz J. Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophr. Res. 2007, 93:13-22.
4. Buchanan R.W., Vladar K., Barta P.E., Pearlson G.D. Structural evaluation of the prefrontal cortex in schizophrenia. Am. J. Psychiatry 1998, 155:1049-1055.
5. Buffo A., Vosko M.R., Ertürk D., Hamann G.F., Jucker M., Rowitch D., Götz M. Expression pattern of the transcription factor Olig2 in response to brain injuries: implications for neuronal repair. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:18183-18188.
6. Cannon T.D., van Erp T.G., Huttunen M., Lönnqvist J., Salonen O., Valanne L., Poutanen V.P., Standertskjöld-Nordenstam C.G., Gur R.E., Yan M. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch. Gen. Psychiatry 1998, 55:1084-1091.
7. Chambers J.S., Perrone-Bizzozero N.I. Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder. Neurochem. Res. 2004, 29:2293-2302.
8. Creese I., Burt D.R., Snyder S.H. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 1976, 192:481-483.
9. Cudrici C., Ito T., Zafranskaia E., Niculescu F., Mullen K.M., Vlaicu S., Judge S.I., Calabresi P.A., Rus H. Dendritic cells are abundant in non-lesional gray matter in multiple sclerosis. Exp. Mol. Pathol. 2007, 83:198-206.
10. Dawson M.R., Levine J.M., Reynolds R. NG2-expressing cells in the central nervous system: are they oligodendroglial progenitors?. J. Neurosci. Res. 2000, 61:471-479.
11. Dawson M.R., Polito A., Levine J.M., Reynolds R. NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol. Cell. Neurosci. 2003, 24:476-488.
12. Fancy S.P., Zhao C., Franklin R.J. Increased expression of Nkx2.2 and Olig2 identifies reactive oligodendrocyte progenitor cells responding to demyelination in the adult CNS. Mol. Cell. Neurosci. 2004, 27:247-254.
13. Ffrench-Constant C., Raff M.C. Proliferating bipotential glial progenitor cells in adult rat optic nerve. Nature 1986, 319:499-502.
14. Franke P., Maier W., Hain C., Klingler T. Wisconsin Card Sorting Test: an indicator of vulnerability to schizophrenia?. Schizophr. Res. 1992, 6:243-249.
15. Franklin R.J. Why does remyelination fail in multiple sclerosis?. Nat. Rev. Neurosci. 2002, 3:705-714.
16. Fukuda S., Konda T., Tajebayashi H., Taga T. Negative regulatory effect of an oligodendrocytic bHLH factor OLIG2 on the astrocytic differentiation pathway. Cell Death Differ. 2004, 11:196-202.
17. Gravel M., Peterson J., Yong V.W., Kottis V., Trapp B., Braun P.E. Overexpression of 2′, 3′-cyclic nucleotide 3′-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination. Mol. Cell. Neurosci. 1996, 7:453-466.
18. Gregg J.R., Herring N.R., Naydenov A.V., Hanlin R.P., Konradi C. Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats. Schizophr. Res. 2009, 113:277-287.
19. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., Haroutunian V., Fienberg A.A. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:4746-4751.
20. Harting M.T., Jimenez F., Adams S.D., Mercer D.W., Cox C.S. Acute, regional inflammatory response after traumatic brain injury: implications for cellular therapy. Surgery 2008, 144:803-813.
21. Hiremath M.M., Saito Y., Knapp G.W., Ting J.P., Suzuki K., Matsushima G.K. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J. Neuroimmunol. 1998, 92:38-49.
22. Horner P.J., Power A.E., Kempermann G., Kuhn H.G., Palmer T.D., Winkler J., Thal L.J., Gage F.H. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J. Neurosci. 2000, 20:2218-2228.
23. Howard S., Landry C., Fisher R., Bezouglaia O., Handley V., Campagnoni A. Postnatal localization and morphogenesis of cells expressing the dopaminergic D2 receptor gene in rat brain: expression in non-neuronal cells. J. Comp. Neurol. 1998, 391:87-98.
24. Islam M.S., Tatsumi K., Okuda H., Shiosaka S., Wanaka A. Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions. Neurochem. Int. 2009, 54:192-198.
25. Katsel P., Davis K.L., Haroutunian V. Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr. Res. 2005, 79:157-173.
26. Keirstead H.S., Levine J.M., Blakemore W.F. Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 1998, 22:161-170.
27. Kitada M., Rowitch D. Transcription factor co-expression patterns indicate heterogeneity of oligodendroglial subpopulations in adult spinal cord. Glia 2006, 54:35-46.
28. Levine J.M. Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury. J. Neurosci. 1994, 14:4716-4730.
29. Levine J.M., Reynolds R. Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination. Exp. Neurol. 1999, 160:333-347.
30. Levine J.M., Enquist L.W., Card J.P. Reactions of oligodendrocyte precursor cells to alpha herpesvirus infection of the central nervous system. Glia 1998, 23:316-328.
31. Ligon K.L., Kesari S., Kitada M., Sun T., Arnett H.A., Alberta J.A., Anderson D.J., Stiles C.D., Rowitch D.H. Development of NG2 neural progenitor cells requires Olig gene function. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:7853-7858.
32. Lu Q.R., Sun T., Zhu Z., Ma N., Garcia M., Stiles C.D., Rowitch D.H. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 2002, 109:75-86.
33. Martin P.M., O'Callaghan J.P. A direct comparison of GFAP immunocytochemistry and GFAP concentration in various regions of ethanol-fixed rat and mouse brain. J. Neurosci. Meth. 1995, 58:181-192.
34. Matsushima G.K., Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001, 11:107-116.
35. Morell P., Barrett C.V., Mason J.L., Toews A.D., Hostettler J.D., Knapp G.W., Matsushima G.K. Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol. Cell. Neurosci. 1998, 12:220-227.
36. Narayan S., Kass K.E., Thomas E.A. Chronic haloperidol treatment results in a decrease in the expression of myelin/oligodendrocyte-related genes in the mouse brain. J. Neurosci. Res. 2007, 85:757-765.
37. Nishiyama A., Yu M., Drazba J.A., Tuohy V.K. Normal and reactive NG2+ glial cells are distinct from resting and activated microglia. J. Neurosci. Res. 1997, 48:299-2312.
38. Niu, J.Q., Mei, F., Li, N., Wang, H.Z., Li, X.M., Kong, J., Xiao, L., in press. Haloperidol promotes proliferation but inhibits differentiation in rat oligodendrocyte progenitor cell cultures. Biochem. Cell Biol.
39. Ong W.Y., Levine J.M. A light and electron microscopic study of NG2 chondroitin sulfate proteoglycan-positive oligodendrocyte precursor cells in the normal and kainate-lesioned rat hippocampus. Neuroscience 1999, 92:83-95.
40. Peirce T.R., Bray N.J., Williams N.M., Norton N., Moskvina V., Preece A., Haroutunian V., Buxbaum J.D., Owen M.J., O'Donovan M.C. Convergent evidence for 2′, 3′-cyclic nucleotide 3′-phosphodiesterase as a possible susceptibility gene for schizophrenia. Arch. Gen. Psychiatry 2006, 63:18-24.
41. Remington L.T., Babcock A.A., Zehntner S.P., Owens T. Microglial recruitment, activation, and proliferation in response to primary demyelination. Am. J. Pathol. 2007, 170:1713-1724.
42. Rosin C., Colombo S., Calver A.A., Bates T.E., Skaper S.D. Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation. Glia 2005, 52:336-343.
43. Sanfilipo M., Lafargue T., Rusinek H., Arena L., Loneragan C., Lautin A., Feiner D., Rotrosen J., Wolkin A. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch. Gen. Psychiatry 2000, 57:471-480.
44. Schachner M., Bartsch U. Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin. Glia 2000, 29:154-165.
45. Setoguchi T., Kondo T. Nuclear export of OLIG2 in neural stem cells is essential for ciliary neurotrophic factor-induced astrocyte differentiation. J. Cell Biol. 2004, 166:963-968.
46. Sokolov B.P. Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies?. Int. J. Neuropsychopharmacol. 2007, 10:547-555.
47. Talbott J.F., Loy D.N., Liu Y., Qiu M.S., Bunge M.B., Rao M.S., Whittemore S.R. Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Exp. Neurol. 2005, 192:11-24.
48. Tatsumi K., Takebayashi H., Manabe T., Tanaka K.F., Makinodan M., Yamauchi T., Makinodan E., Matsuyoshi H., Okuda H., Ikenaka K., Wanaka A. Genetic fate mapping of Olig2 progenitors in the injured adult cerebral cortex reveals preferential differentiation into astrocytes. J. Neurosci. Res. 2008, 86:3494-3502.
49. Watanabe M., Toyama Y., Nishiyama A. Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. J. Neurosci. Res. 2002, 69:826-836.
50. Wennstrom M., Hellsten J., Ekdahl T.C., Tingstrom A. Electroconvulsive seizures induce proliferation of NG2-expressing glia cells in adult rat hippocampus. Biol. Psychiatry 2003, 54:1015-1024.
51. Wennstrom M., Hellsten J., Tingstrom A. Electroconvulsive seizures induce proliferation of NG2-expressing glia cells in adult rat amygdala. Biol. Psychiatry 2004, 55:464-471.
52. Wu Q., Howell M.P., Palmiter R.D. Ablation of neurons expressing agouti-related protein activates fos and gliosis in postsynaptic target regions. J. Neurosci. 2008, 28:9218-9226.
53. Xiao L., Xu H., Zhang Y., Wei Z., He J., Jiang W., Li X., Dyck L.E., Devon R.M., Deng Y., Li X.M. Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Mol. Psychiatry 2008, 13:697-708.
54. Xu H., Yang H.J., Zhang Y., Clough R., Browning R., Li X.M. Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone. Behav. Neurosci. 2009, 123:418-429.
55. Yang H.J., Wang H., Zhang Y., Xiao L., Clough R.W., Browning R., Li X.M., Xu H. Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: implications for the pathophysiology of schizophrenia. Brain Res. 2009, 1270:121-130.
56. Zhang Y., Xu H., Jiang W., Xiao L., Yan B., He J., Wang Y., Bi X., Li X., Kong J., Li X.M. Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse. Schizophr. Res. 2008, 106:182-191.
57. Zhao J.W., Raha-Chowdhury R., Fawcett J.W., Watts C. Astrocytes and oligodendrocytes can be generated from NG2+ progenitors after acute brain injury: intracellular localization of oligodendrocyte transcription factors 2 is asscoaited with their fate choice. Eur. J. NeuroSci. 2009, 29:1853-1869.
58. Zhou Q., Anderson D.J. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 2002, 109:61-73.